KOSUNI CRYPTO
Korea's Crypto Pulse, in English
$BTC $ETH $XRP $SOL $DOGE
Regulation
Neutral

Chinese Biotech Stocks Rise on US Approval for Pharmaceutical License Deals

Published September 21, 2026 1:38 PM · 5 views
Chinese Biotech Stocks Rise on US Approval for Pharmaceutical License Deals

Chinese biotech stocks rose after a report revealed that the U.S. may continue to allow most pharmaceutical licensing deals between Chinese and American firms. CNBC reported on October 21 that the U.S. is reviewing a plan to permit such transactions, while Reuters had earlier stated on October 18 that the U.S. Treasury Department is preparing measures to restrict trade involving biotechnology that could be weaponized.

The proposed policy aims to regulate specific sectors related to national security rather than imposing a full ban on transactions between Chinese biotech companies and American pharmaceutical firms, according to reports.

Korean Source

This article is an English localization of a Korean-language crypto news report. Original headline: 중국 바이오주, 美 의약품 거래 허용 소식에 상승